Immucor,
Inc. develops, manufactures and sells a line of products and systems
used by medical facilities to evaluate the properties of certain components of
human blood. (Ticker: BLUD; Exch: NASD;
10/01/02 Price: $17.12/shr.)
STOCK'S CORE STRENGTHS:
Management's Effectiveness (12 Mo.) |
. . . |
Return on Equity: |
26.41% |
|
Profitability (12 Mo.) |
. . . |
Profit Margin: |
11.88% |
|
Stock's Growth Record (12 Mo.) |
. . . |
Revenue: |
21.18% |
| . . . |
EPS: |
--- % |
| . . . |
Price: |
420.20% |
| . . . |
Dividend: |
---% |
|
PE & EPS (12 Mo.) |
. . . |
Price/Earnings: |
23.16 |
| . . . |
Earnings/Share: |
0.87 |
STOCK'S 12-MONTH GAIN
(LOSS),
10/01/02 - 10/01/03: 68.63%
STOCK'S 48-MONTH GAIN (10/01/02 - 10/01/06) GAIN: 5Y63.02
($3.38sh. - $22.41sh.)
STOCK INFO: Stock
information you may need to evaluate this stock and make
smart investment
decisions
(Company profile, analyst
rating, price history, price
chart, financial statement,
earnings, competition, fundamentals,
stock performance, stock valuation, stock
quotes, annual reports,
company
performance, institutional holdings, latest news, inside trading, discussions, more.
Source:http://www.stockadvanced.com/).